Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
Paclitaxel
Abraxis Bioscience Australia Pty Ltd
Medicine Registered
August 2013 CMI FOR ABRAXANE ________________________________________________________________________________ ABX_CMI_AUNZ_Alignment_Final_02Sep13 1 ABRAXANE ® Paclitaxel_ (pak-li-TAX-el) _ CONSUMER MEDICINE INFORMATION _ _ _ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ABRAXANE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given ABRAXANE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR. YOUR DOCTOR OR PHARMACIST CAN PROVIDE YOU WITH MORE INFORMATION ABOUT ABRAXANE. KEEP THIS LEAFLET_ _ You may need to read it again. WHAT ABRAXANE IS USED FOR This medicine is used to treat: • Breast cancer • Lung Cancer This medicine belongs to a group of medicines called antineoplastic or cytotoxic medicines. You may also hear of these being called chemotherapy medicines. It works by killing cancer cells and stopping them from multiplying. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is not addictive. This medicine is available only with a doctor’s prescription_. _ BEFORE YOU ARE GIVEN ABRAXANE _WHEN YOU MUST NOT BE GIVEN IT _ YOU MUST NOT BE GIVEN ABRAXANE IF YOU HAVE AN ALLERGY TO: • any medicine containing paclitaxel • any of the ingredients listed at the end of this leaflet Some of the symptoms of an allergic reaction may Baca dokumen lengkapnya
ABRAXANE ® Powder for Injection (suspension) Abraxis BioScience Australia Pty Ltd Product Information (an indirect subsidiary of Celgene Corporation) ABX_PI_AUNZ_Alignment_Final_02Sep13 _ _ _1 of 23 _ ABRAXANE ® PRODUCT INFORMATION NAME OF THE MEDICINE ABRAXANE (nanoparticle albumin-bound paclitaxel) 100 mg powder for injection (suspension). The empirical formula for Paclitaxel is C 47 H 51 NO 14. The CAS Number for paclitaxel is 33069-62-4. The chemical name for paclitaxel is 5β,20-Epoxy-1,2α,4,7β,10β,13α- hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2_R_,3_S_)-_N_-benzoyl-3- phenylisoserine. Paclitaxel has the following chemical structure: DESCRIPTION ABRAXANE (nanoparticle albumin-bound paclitaxel) 100 mg powder for injection (suspension) is an albumin nanoparticle form of paclitaxel with a mean particle size of approximately 130 nanometres. Paclitaxel exists in the nanoparticles in a non-crystalline, amorphous state. Each vial of ABRAXANE contains paclitaxel and human albumin in the ratio of 1:9. The paclitaxel is contained within nanoparticles that consist of a majority of paclitaxel bound to human albumin. ABRAXANE is supplied as a white to yellow, sterile, lyophilised powder in a 50 mL glass vial. Each single-use vial contains the following: Paclitaxel 100 mg _Excipients: _ Human albumin solution (containing sodium, sodium octanoate and N-acetyl tryptophan). The reconstituted medicinal product contains approximately 85 mg sodium per vial. ABRAXANE is free of solvents. The active agent in ABRAXANE is paclitaxel, a natural product with antitumour activity. Paclitaxel is obtained from _Taxus media_. Paclitaxel is a white to off-white crystalline powder with a molecular weight of 853.91. It is highly lipophilic, insoluble Baca dokumen lengkapnya